Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thalassemia × Mesna × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Leukemia 15 Lymphoma, Non-Hodgkin 14 Sarcoma 9 Leukemia, Myeloid, Acute 9 Hodgkin Disease 9 Hematologic Neoplasms 9 Myelodysplastic Syndromes 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Neoplasms 6 Osteosarcoma 5 Neuroblastoma 5 Lymphoma, Mantle-Cell 5 Lymphoma, Follicular 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Breast Neoplasms 5 Retinoblastoma 4 Multiple Myeloma 4 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Burkitt Lymphoma 4 Wilms Tumor 3 Rhabdoid Tumor 3 Neoplasms, Germ Cell and Embryonal 3 Myeloproliferative Disorders 3 Medulloblastoma 3 Hepatoblastoma 3 Graft vs Host Disease 3 Carcinoma, Hepatocellular 3

Interventions

fludarabine 4 fludarabine phosphate 3 Cyclophosphamide 3 thymoglobulin 1 Whole-Body Irradiation 1 Thiotepa 1 Tacrolimus 1 Rituximab 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Erythrocyte Count 1 Dexamethasone 1 Clofarabine 1 Busulfan 1 Bortezomib 1 Blood Transfusion 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00578292 2020-05-01

THALLO

Baylor College of Medicine

Phase NA Terminated

10 enrolled 15 charts

Lymphoma, Follicular, Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡